Predicting vascular complications in percutaneous coronary interventions

被引:162
作者
Piper, WD
Malenka, DJ
Ryan, TJ
Shubrooks, SJ
O'Connor, GT
Robb, JF
Farrell, KL
Corliss, MS
Hearne, MJ
Kellett, MA
Watkins, MW
Bradley, WA
Hettleman, BD
Silver, TM
McGrath, PD
O'Mears, JR
Wennberg, DE
机构
[1] Dartmouth Coll, Hitchcock Med Ctr, Clin Res Sect, Dept Med, Lebanon, NH 03756 USA
[2] Dartmouth Coll, Hitchcock Med Ctr, Cardiol Sect, Lebanon, NH 03756 USA
[3] Maine Med Ctr, Div Cardiol, Portland, ME 04102 USA
[4] Maine Med Ctr, Dept Med, Div Hlth Serv Res, Portland, ME 04102 USA
[5] Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA
[6] Dartmouth Coll Sch Med, Ctr Evaluat & Clin Sci, Hanover, NH USA
[7] Fletcher Allen Hlth Care, Div Cardiol, Burlington, VT USA
[8] Concord Reg Hosp, Concord, NH USA
[9] Catholic Med Ctr, Manchester, NH USA
[10] Eastern Maine Med Ctr, Bangor, ME USA
关键词
D O I
10.1016/S0002-8703(03)00079-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives using a large, current, regional registry of percutaneous coronary interventions (PCI), we identified risk factors for postprocedure vascular complications and developed a scoring system to estimate individual patient risk. Background A vascular complication (access-site injury requiring treatment or bleeding requiring transfusion) is a potentially avoidable outcome of PCI. Methods Data were collected on 18,137 consecutive patients undergoing PCI in northern New England from January 1997 to December 1999. Multivariate regression was used to identify characteristics associated with vascular complications and to develop a scoring system to predict risk. Results The rate of vascular complication was 2.98% (541 cases). Variables associated with increased risk in the multivariate analysis included age 70, odds ratio (OR) 2.7, female sex (OR 2.4), body surface area <1.6 m(2) (OR 1.9), history of congestive heart failure (OR 1.4), chronic obstructive pulmonary disease (OR 1.5), renal failure (OR 1.9), lower, extremity vascular disease (OR 1.4), bleeding disorder (OR 1.68), emergent priority (OR 2.3), myocardial infarction (OR 1.7), shock (1.86), >= 1 type B2 (OR 1.32) or type C (OR 1.7) lesions, 3-vessel PCI (OR 1.5), use of thienopyriclines (OR 1.4) or use of glycoprotein IIb/IIIa receptor inhibitors (OR 1.9). The model performed well in tests for significance, discrimination, and calibration. The scoring system captured 75% of actual vascular complications in its highest quintiles of predicted risk. Conclusion Predicting the risk of post-PCI vascular complications is feasible. This information may be useful for clinical decision-making and institutional efforts at quality improvement.
引用
收藏
页码:1022 / 1029
页数:8
相关论文
共 33 条
[1]   BLEEDING COMPLICATIONS WITH THE CHIMERIC ANTIBODY TO PLATELET GLYCOPROTEIN IIB/IIIA INTEGRIN IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION [J].
AGUIRRE, FV ;
TOPOL, EJ ;
FERGUSON, JJ ;
ANDERSON, K ;
BLANKENSHIP, JC ;
HEUSER, RR ;
SIGMON, K ;
TAYLOR, M ;
GOTTLIEB, R ;
HANOVICH, G ;
ROSENBERG, M ;
DONOHUE, TJ ;
WEISMAN, HF ;
CALIFF, RM .
CIRCULATION, 1995, 91 (12) :2882-2890
[2]  
[Anonymous], 1986, Statistical Science, DOI [10.1214/ss/1177013815, DOI 10.1214/SS/1177013815]
[3]  
Bazzino O, 1998, NEW ENGL J MED, V338, P1488
[4]   Vascular access site complications after percutaneous coronary intervention with abciximab in the evaluation of c7E3 for the prevention of ischemic complications (EPIC) trial [J].
Blankenship, JC ;
Hellkamp, AS ;
Aguirre, FV ;
Demko, SL ;
Topol, EJ ;
Califf, RM .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (01) :36-40
[5]   USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].
CALIFF, RM ;
SHADOFF, N ;
VALETT, N ;
BATES, E ;
GALEANA, A ;
KNOPF, W ;
SHAFTEL, J ;
BENDER, MJ ;
AVERSANO, T ;
RAQUENO, J ;
GURBEL, P ;
COWFER, J ;
COHEN, M ;
CROSS, P ;
BITTL, J ;
EDDINGS, K ;
TAYLOR, M ;
DEROSA, K ;
HATTEL, L ;
COOPER, L ;
ESHELMAN, B ;
FINTEL, D ;
NIEMYSKI, P ;
KLEIN, L ;
KENNEDY, H ;
THORNTON, T ;
KEREIAKES, D ;
MARTIN, L ;
ANDERSON, L ;
HIGBY, N ;
ELLIS, S ;
BREZINA, K ;
GEORGE, B ;
CHAPEKIS, A ;
SMITH, D ;
ANWAR, A ;
GERBER, TL ;
PRITCHARD, GL ;
MYLER, R ;
SHAW, R ;
MURPHY, M ;
WARD, K ;
MADIGAN, NP ;
BLANKENSHIP, J ;
HALBERT, M ;
FLANAGAN, C ;
TANNENBAUM, M ;
POLICH, M ;
STEVENSON, C ;
TCHENG, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961
[6]  
*CAPTURE INV, 1997, LANCET, V350, P744
[7]   Vascular complications of coronary interventions [J].
Davis, C ;
VanRiper, S ;
Longstreet, J ;
Moscucci, M .
HEART & LUNG, 1997, 26 (02) :118-127
[8]   THE MEANING AND USE OF THE AREA UNDER A RECEIVER OPERATING CHARACTERISTIC (ROC) CURVE [J].
HANLEY, JA ;
MCNEIL, BJ .
RADIOLOGY, 1982, 143 (01) :29-36
[9]  
Hanrath P, 1997, CIRCULATION, V96, P1445
[10]  
Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO